Zobrazeno 1 - 4
of 4
pro vyhledávání: '"556"'
Autor:
Fukuyama T; Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Hanagiri T, Takenoyama M, Ichiki Y, Mizukami M, So T, Sugaya M, So T, Sugio K, Yasumoto K
Publikováno v:
Cancer research [Cancer Res] 2006 May 01; Vol. 66 (9), pp. 4922-8.
Publikováno v:
Cancer Research. 81:PO-051
Tumor Treating Fields (TTFields) are a non-invasive, loco-regional antimitotic treatment modality, approved for the treatment of glioblastoma and malignant pleural mesothelioma. TTFields at a specific frequency (150-200 kHz) are delivered via arrays
Publikováno v:
Cancer Research. 79:CT176-CT176
Background: Tumor Treating Fields (TTFields) are a non-invasive, regional antimitotic treatment modality, which has been approved for the treatment of patients with glioblastoma by the FDA. TTFields predominantly act by disrupting the formation of th
Autor:
Takeshi Hanagiri, Mitsuhiro Takenoyama, Kenji Sugio, Kosei Yasumoto, Makiko Mizukami, Tetsuya So, Masakazu Sugaya, Fukuyama Takashi, Yoshinobu Ichiki, Tomoko So
Publikováno v:
Cancer research. 66(9)
The purpose of our present study is to identify a tumor-specific antigen capable of inducing a specific cellular immune response in lung cancer patients. We established a lung adenocarcinoma cell line, designated as F1121L, and induced tumor-specific